Gliadel
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background: Carmustine (BCNU) wafers (Gliadel) prolongs local disease control and progression-free survival (PFS) in patients…
Objective. The prognosis of high-grade glioma (HGG) is poor with a median survival of about 1 year for glioblastoma. In 2007…
Health-related quality of life (HRQOL) has recently become an important outcome measure in neuro-oncology. At present, no single…
In patients with glioblastoma multiforme (GBM), there is no consensus on the sequential use of two existing regimens: post…
Loco-regional chemotherapy with carmustine wafers (Gliadel) positioned at surgery and followed by radiotherapy has been shown to…
OBJECTIVE To report a case of Candida meningitis post Gliadel wafer (polifeprosan 20 with carmustine implant) placement…
13003 Background: Improved survival of patients with newly diagnosed malignant glioma has been acheived with the addition of…
11504 Background: Treatment of patients with newly diagnosed malignant glioma using Gliadel wafer implantation at initial surgery…
Randomized trials have demonstrated Gliadel® improves survival for appropriately selected patients with newly diagnosed malignant…
The results of a recently concluded phase III study have shown that Gliadel therapy (biodegradable polymer impregnated with 3.85…